Fertility drugs are medications that are taken to help with conception and pregnancy. They may be prescribed for a variety of reasons, such as to stimulate ovulation, to increase the number of eggs produced by the ovaries, or to regulate hormone levels. They can be used in combination with in vitro fertilization (IVF) or other assisted reproductive technologies (ART). The most commonly used fertility drug is clomiphene citrate, or Clomid. Clomid works by stimulating the production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH helps to trigger the development of follicles in the ovaries, while LH helps to trigger the release of an egg. Clomid can be taken orally and usually begins working within the first few days of the menstrual cycle. Other fertility drugs include gonadotropins such as FSH and LH, which are injected directly into the body. These drugs help to increase the number of eggs produced by the ovaries. They may also be used to treat some types of infertility, such as unexplained infertility or endometriosis. In some cases, fertility drugs may be used in combination with other treatments, such as IUI (intrauterine insemination) or IVF. They may also be used in combination with lifestyle changes, such as changes in diet or exercise, to help improve fertility. Fertility drugs are generally safe, but they can cause some side effects, such as hot flashes, headaches, breast tenderness, and nausea. Some fertility drugs may also increase the risk of having a multiple pregnancy, so it is important to discuss any potential risks with your doctor before beginning treatment.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia